BEDFORD, Mass., Mar 08, 2010 (BUSINESS WIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced that Charles Sherwood, president and chief executive officer, will be presenting at the Canaccord Adams Musculoskeletal Conference on Tuesday, March 9, 2010 at 9:00 a.m. CT (10:00 a.m. ET). A live audio webcast of the presentation may be accessed via the Internet at:http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2953940. In addition, the presentation will be available live at the "Investors" section of Anika's website at www.anikatherapeutics.com. Dr. Sherwood will be discussing the current state of the business, including the Company's recent acquisition of Fidia Advanced Biopolymers.

About Anika Therapeutics, Inc.

Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing, repair and regeneration. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Anika's products range from orthopedic/joint health solutions led by ORTHOVISC®, a treatment for osteoarthritis of the knee; to surgical aids in the ophthalmic and anti-adhesion fields. The company also offers aesthetic dermal fillers for the correction of facial wrinkles. Anika's Italian subsidiary, Fidia Advanced Biopolymers, S.r.l (FAB), provides complementary HA products in orthopedic/joint health and anti-adhesion, as well as therapeutics in new areas such as advanced wound treatment and ear, nose and throat care. FAB's regenerative tissue technology advances Anika's vision to offer therapeutic products that go beyond pain relief to protect and restore damaged tissue.

SOURCE: Anika Therapeutics

Anika Therapeutics, Inc.
Charles H. Sherwood, Ph.D., CEO
Kevin W. Quinlan, CFO
781-457-9000